Cargando…
Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization
BACKGROUND: The sites of mycobacterial infection in the lungs of tuberculosis (TB) patients have complex structures and poor vascularization, which obstructs drug distribution to these hard-to-reach and hard-to-treat disease sites, further leading to suboptimal drug concentrations, resulting in comp...
Autores principales: | Strydom, Natasha, Gupta, Sneha V., Fox, William S., Via, Laura E., Bang, Hyeeun, Lee, Myungsun, Eum, Seokyong, Shim, TaeSun, Barry, Clifton E., Zimmerman, Matthew, Dartois, Véronique, Savic, Radojka M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445413/ https://www.ncbi.nlm.nih.gov/pubmed/30939136 http://dx.doi.org/10.1371/journal.pmed.1002773 |
Ejemplares similares
-
The association between sterilizing activity and drug distribution into tuberculosis lesions
por: Prideaux, Brendan, et al.
Publicado: (2015) -
Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary Tuberculosis
por: Ernest, Jacqueline P., et al.
Publicado: (2021) -
Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis
por: Fors, John, et al.
Publicado: (2020) -
Natural killer cells are recruited during pulmonary tuberculosis and their ex vivo responses to mycobacteria vary between healthy human donors in association with KIR haplotype
por: Portevin, Damien, et al.
Publicado: (2012) -
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
por: Lenaerts, Anne, et al.
Publicado: (2015)